Inhibition of lipocalin in mdx mice via either Lcn2 knockout or the administration of lipocalin monoclonal antibody has shown increased trabecular volume, enhanced grip strength, and decreased diaphragm fibrosis (100), indicating that it may play an important role in both skeletal muscle and bone pathologies in DMD. The gene discussed is LCN2; the disease is Duchenne muscular dystrophy.